Created at	Source	Raw Value	Validated value
Feb. 8, 2022, 2:30 p.m.	usa	SARS-CoV-2 binding antibodies;SARS-CoV-2 neutralization antibodies;Solicited clinical (local and systemic), laboratory, and unsolicited adverse events;Solicited clinical (local and systemic), laboratory, and unsolicited adverse events;Th1 and Th2	SARS-CoV-2 binding antibodies;SARS-CoV-2 neutralization antibodies;Solicited clinical (local and systemic), laboratory, and unsolicited adverse events;Solicited clinical (local and systemic), laboratory, and unsolicited adverse events;Th1 and Th2